GeneDx study finds 62% of patients with pathogenic or likely pathogenic findings have actionable results
WGS•GeneDx said research on sequencing results from more than 300,000 patients found that 62% of patients with pathogenic or likely pathogenic findings had medically actionable results.
1. Study findings
GeneDx announced research on exome and genome sequencing results from more than 300,000 patients. The findings indicate genetic results could help guide treatment, disease surveillance and long-term care.
2. Conference presentation
The results are scheduled to be presented at the National Society of Genetic Counselors annual conference, Nov. 11-14, 2026.
